Stay updated with breaking news from Jackk Allen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Taysha Gene Therapies faces potential delisting of its shares—the latest in a series of setbacks that include scrapping a $75-million manufacturing facility in Durham, NC.
Johnson & Johnson shares rose and fell on events that included Q1 results, leaked data, and a temporary halt to 38,000 talc product lawsuits.
Nine analysts raise stock price targets for Apellis Pharmaceuticals after it wins the FDA's first approval for a geographic atrophy therapy.